On 2024-11-13, Elicio Therapeutics, Inc. (ELTX) announced earnings per share of $-1.39 for the fiscal quarter ending 2024-09-30, missing the average analyst estimate of $-0.81.
The next expected annoucement date for quarterly earnings is 2025-04-04, with an average estimated earnings per share of $-0.94 for the fiscal quarter ending 2024-12-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-11-13 | 2024-09-30 | $-0.81 | $-1.39 |
| 2024-08-13 | 2024-06-30 | $-0.96 | $-0.64 |
| 2024-05-15 | 2024-03-31 | $-1.09 | $-1.15 |
| 2024-03-29 | 2023-12-31 | -- | $-3.77 |
| 2023-11-09 | 2023-09-30 | $-0.80 | $-1.27 |
| 2023-08-11 | 2023-06-30 | -- | $-2.61 |
| 2023-05-10 | 2023-03-31 | $-5.40 | $-1.50 |
| 2023-03-17 | 2022-12-31 | -- | $-1.10 |
| 2022-11-14 | 2022-09-30 | $-3.60 | $-2.10 |
| 2022-08-15 | 2022-06-30 | $-4.60 | $-3.00 |
| 2022-05-16 | 2022-03-31 | $-4.40 | $-4.80 |
| 2022-03-30 | 2021-12-31 | $-5.90 | $5.80 |
| 2021-11-12 | 2021-09-30 | $-7.30 | $-5.30 |
| 2021-08-12 | 2021-06-30 | $-6.90 | $-5.80 |
| 2021-05-17 | 2021-03-31 | $-6.20 | $-9.40 |
| 2021-03-30 | 2020-12-31 | $-13.00 | $-19.00 |